A new database has tracked the biggest winners and losers in activist short-selling. Pershing Square’s Bill Ackman, despite Herbalife, is one of the best; David Einhorn of Greenlight Capital, isn’t.
The hedge fund titan’s Pershing Square Capital is set to conduct an IPO later this year, but industry insiders are worried Ackman is sabotaging its potential success with his increasingly bizarre public behavior.
During the company’s second quarter earnings call, CEO Michael Johnson defended Herbalife’s earnings miss and recent hiring of a government affairs official by sharing his grand vision for its future. The comments come a week after Bill Ackman’s Herbalife presentation in New York at which he vehemently insisted the company was a giant pyramid scheme.
Today, billionaire hedge fund manager Bill Ackman of Pershing Square Capital gave a three-and-a-half-hour presentation about Herbalife, the company he has a $1 billion short position in, and which he’s spent $50 million to date trying to take down. Things got…weird.
With the nutritional supplement under investigation by multiple regulators and law enforcement agencies, Ackman presses his case with a film featuring former Herbalife distributors.
Hedge fund activist Bill Ackman’s crusade against Herbalife gets government boost.
New data from Activist Insight suggests that activist investing for 2014 is already shaping up to outpace last year, and the companies targeted represent a diverse group of industries.
Pershing Square Capital has launched a new website attacking former Herbalife employees. Experts say the hedge fund could be in questionable legal territory with its “unprecedented” move.
A series of regulatory investigations and an analyst defecting has made for quite the wild ride for Herbalife stock.
Massachusetts senator Ed Markey wrote letters to the Federal Trade Commission and the Securities and Exchange Commission: “There is nothing nutritional about possible pyramid schemes.”
This was the year the proxy battle turned ugly—and went mainstream.
Herbalife has fired back at activist investor and hedge fund titan Bill Ackman, who has been telling investors to sell its stock for nearly a year, with a tactic so aggressive that it could harm rather than help the supplement company.
Contentious hedge fund manager and activist investor Daniel Loeb is usually tight-lipped about the controversies that surround him. But at today’s New York Times DealBook Conference, Loeb dropped some bombs and addressed his critics, including George Clooney.
The controversial nutritional supplements company beat analysts’ expectations again but is still shelling out to fight the PR battle with its hedge fund antagonist.
In his quarterly investor letter, Ackman described D.A. Davidson analyst Timothy Ramey as “perennially bullish” on Herbalife and said that investors think he’s “speaking on behalf of the Company.” Ramey today said in a note that Ackman has capitulated and is at higher risk of losing his entire $1 billion short bet.
The embattled hedge fund manager and activist investor Bill Ackman detailed his investment failings and mistakes in a letter yesterday, despite his firm’s decent performance.
In a wide-ranging interview on PBS’ Charlie Rose show Tuesday night, Ackman defended his recent actions against J.C. Penney and himself against attacks from rivals.
UPDATED: A series of dramatic letters and erratic behavior by billionaire hedge fund manger Bill Ackman isn’t helping his activist investment efforts with J.C. Penney and Herbalife. His decision to resign from the board of J.C. Penney on Tuesday caps a year of public battles and strange moves, but is it too little, too late?
Herbalife, a dietary supplement company that has captured the intense focus of three of the hedge fund world’s most influential investors, continues to rake in capital, most recently from George Soros. Four, if you count Daniel Loeb.
Icahn is as well known for his fiery temper and pointed one-liners as he is for his hedge fund’s activist investing.
Some of Wall Street’s top companies have come under fire from investors fed up with their current management and financial performance and agitating for change. Call it the golden age of the activist.